Delivery Order SPE2DB20D7059-SPE2DB25FQES9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $55,560.43 for BIKTARVY 50-200-25 mg tablets (30-count units) by the Defense Logistics Agency on September 9, 2025. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by September 10, 2025, with performance taking place at the company's Conshohocken facility. The award represents a child...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $128,852.06 for the supply of BIKTARVY 50-200-25 mg tablets in packages of 30 units. Awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,715.77 by the Defense Logistics Agency on July 22, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 23, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) valued at $8,263.10 for Biktarvy 50-200-25 mg tablets (30-count units). The award, made on August 6, 2025, represents a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,792.90 by the Defense Logistics Agency for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and was competitively awarded without set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,248.66 on May 16, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 19, 2025, and performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $210,550.92 on September 27, 2025, for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) to support the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $51,148.62 for Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed price delivery order with a completion date of July 29, 2025, and was awarded on July 28, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $48,473.90 and is scheduled for completion by August 13, 2025. The contract includes no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a $14.76K delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) under a firm fixed-price contract, with an ultimate completion date of September 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award involved no set-aside designation,...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQES9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $9,288.90 by the Defense Logistics Agency for BIKTARVY 30-120-15 mg tablets (30-count supply). The contract, awarded on April 23, 2025, with an ultimate completion date of April 24, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement running through December 2026 that enables the company to deliver medications and medical supplies globally to support military healthcare programs. The award reflects AmerisourceBergen's role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. BIKTARVY, an antiretroviral medication used in HIV treatment, will be delivered from the company's Conshohocken, Pennsylvania location. This transaction exemplifies the company's capability to fulfill diverse federal medical procurement requirements through competitive processes, with its extensive portfolio encompassing brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 4/23/25 |